ondasdechoque.org
PT-BR

Plantar heel pain / plantar fasciopathy · Randomized trial · 2025

How does radial shockwave compare with physiotherapy and ultrasound for heel pain?

In this trial, heel pain fell from about 9 to about 3.5 out of 10 over six months with six sessions of radial shockwave, one a week. People who had 12 physiotherapy sessions with ultrasound improved by about the same amount.

Both helped
adults with heel pain
129
sessions, one a week
6
months of follow-up
6

Good to know: Run at a rehabilitation department in Tunisia. The 12-month follow-up was still under way.

Ines L, Rihab M, Sana B, et al. BMC Musculoskeletal Disorders, 2025 · Read the paper ↗

How this study worked

Shockwave66 peoplePhysio + ultrasound63 people
People were assigned to the groups by lot. Each dot is one person.

What happened

Heel pain

0–10 pain scale · start, then 1, 3 and 6 months after treatment

ShockwavePhysio + ultrasound

Pain fell from about 9 to about 5 out of 10 a month after treatment in both groups, and to about 3.5 by six months.
Show the numbers
GroupStart1 month3 months6 months
Shockwave9.044.94.333.56
Physio + ultrasound9.44.74.53.42

The treatment

Shockwave

Radial, once a week for 6 weeks

Radial wavesSpread out from the skin; strongest near the surface
Sessions
6, one a week
Pulses
2,000 per session
Strength
2.5bar · 10 per second
Numbing
Not mentioned
Device
BTL-6000

Compared with: 12 physiotherapy sessions over 4 weeks: stretching, deep massage and ultrasound

Settings are what each study used, not a prescription.

Who took part

129 adults aged 18 to 70 with heel pain for more than three months, at a rehabilitation department in Tunisia.

Shockwave66 people
Physio + ultrasound63 people

Side effects

The report did not list side effects.

All the numbers and the full appraisal
FROM THE FULL PAPER

The results, in numbers.

Adults aged 18–70 with plantar fasciitis symptoms lasting over three months and baseline activity VAS ≥5, randomized to radial ESWT or physiotherapy plus ultrasound at a Tunisian rehabilitation department. The article reports 129 randomized (66 and 63); 4 lacked baropodometric data.

Radial ESWT66randomized

129 total randomized; baropodometric table reports 65 participants. VAS and success outcome denominators are not fully clear in the article.

Physiotherapy plus ultrasound63randomized

129 total randomized; baropodometric table reports 60 participants. VAS and success outcome denominators are not fully clear in the article.

Pain intensity (VAS)4 reported outcomes
01
End of treatment; baseline before treatment

Pain intensity (VAS)

Visual Analogue Scale (0–10 cm, source-defined) VAS points

BaselineFollow-up
Radial ESWT
5.53
Physiotherapy plus ultrasound
5.57
010 VAS points
means
GroupnBaselineFollow-up
Radial ESWT—9.04 (SD 0.95)5.53 (SD 1.34)
Physiotherapy plus ultrasound—9.4 (SD 0.75)5.57 (SD 1.25)

SD: standard deviation. CI: confidence interval. IQR: interquartile range. —: not extracted.

REPORTED COMPARISON TESTp = 0.858

ESWT versus physiotherapy plus ultrasound at the end of treatment; no significant between-group difference.

Student's t-test between groups (Methods, Statistical analysis; Table 3 P value column)

The stored group values are the end-of-treatment means; the 1-, 3- and 6-month means are stored as separate outcomes. Table 3 means (SD): baseline 9.04 (0.95) vs 9.4 (0.75), p=0.013; end treatment 5.53 (1.34) vs 5.57 (1.25), p=0.858; 1 month 4.9 (1.57) vs 4.7 (1.6), p=0.525; 3 months 4.33 (2.00) vs 4.5 (1.99), p=0.479; 6 months 3.56 (2.48) vs 3.42 (2.21), p=0.751. The source says no significant between-group difference after treatment; baseline pain differed.

Analysis details and source

No between-group effect estimate or confidence interval reported; nonsignificance is not equivalence.

02
1 month after treatment; baseline before treatment

Pain intensity (VAS)

Visual Analogue Scale (0–10 cm, source-defined) VAS points

BaselineFollow-up
Radial ESWT
4.9
Physiotherapy plus ultrasound
4.7
010 VAS points
means
GroupnBaselineFollow-up
Radial ESWT—9.04 (SD 0.95)4.9 (SD 1.57)
Physiotherapy plus ultrasound—9.4 (SD 0.75)4.7 (SD 1.6)

SD: standard deviation. CI: confidence interval. IQR: interquartile range. —: not extracted.

REPORTED COMPARISON TESTp = 0.525

ESWT versus physiotherapy plus ultrasound one month after treatment; no significant between-group difference.

Student's t-test between groups (Methods, Statistical analysis; Table 3 P value column)

Table 3 means (SD) one month after treatment: 4.9 (1.57) with ESWT vs 4.7 (1.6) with physiotherapy plus ultrasound, p=0.525. Both groups improved from baseline (intragroup p<0.05, Table 3 footnote); baseline pain differed (9.04 vs 9.4, p=0.013).

Analysis details and source

No between-group effect estimate or confidence interval reported; nonsignificance is not equivalence.

03
3 months after treatment; baseline before treatment

Pain intensity (VAS)

Visual Analogue Scale (0–10 cm, source-defined) VAS points

BaselineFollow-up
Radial ESWT
4.33
Physiotherapy plus ultrasound
4.5
010 VAS points
means
GroupnBaselineFollow-up
Radial ESWT—9.04 (SD 0.95)4.33 (SD 2)
Physiotherapy plus ultrasound—9.4 (SD 0.75)4.5 (SD 1.99)

SD: standard deviation. CI: confidence interval. IQR: interquartile range. —: not extracted.

REPORTED COMPARISON TESTp = 0.479

ESWT versus physiotherapy plus ultrasound three months after treatment; no significant between-group difference.

Student's t-test between groups (Methods, Statistical analysis; Table 3 P value column)

Table 3 means (SD) three months after treatment: 4.33 (2.00) with ESWT vs 4.5 (1.99) with physiotherapy plus ultrasound, p=0.479. Both groups improved from baseline (intragroup p<0.05, Table 3 footnote); baseline pain differed (9.04 vs 9.4, p=0.013).

Analysis details and source

No between-group effect estimate or confidence interval reported; nonsignificance is not equivalence.

04
6 months after treatment; baseline before treatment

Pain intensity (VAS)

Visual Analogue Scale (0–10 cm, source-defined) VAS points

BaselineFollow-up
Radial ESWT
3.56
Physiotherapy plus ultrasound
3.42
010 VAS points
means
GroupnBaselineFollow-up
Radial ESWT—9.04 (SD 0.95)3.56 (SD 2.48)
Physiotherapy plus ultrasound—9.4 (SD 0.75)3.42 (SD 2.21)

SD: standard deviation. CI: confidence interval. IQR: interquartile range. —: not extracted.

REPORTED COMPARISON TESTp = 0.751

ESWT versus physiotherapy plus ultrasound six months after treatment; no significant between-group difference.

Student's t-test between groups (Methods, Statistical analysis; Table 3 P value column)

Table 3 means (SD) six months after treatment: 3.56 (2.48) with ESWT vs 3.42 (2.21) with physiotherapy plus ultrasound, p=0.751. Both groups improved from baseline (intragroup p<0.05, Table 3 footnote); baseline pain differed (9.04 vs 9.4, p=0.013).

Analysis details and source

No between-group effect estimate or confidence interval reported; nonsignificance is not equivalence.

Treatment success at 3 months (RMS)1 reported outcome
05
3 months

Treatment success at 3 months (RMS)

Roles and Maudsley score; success defined as good/excellent responder reported responders and percent

Table 4 shows excellent/good counts of 22/29 in ESWT and 20/23 in physiotherapy; the prose reports success rates as 54% versus 46% and p=0.250. The denominators/percentages are internally unclear, and another section defines success using alternative VAS criteria. Preserve the reported values as conflicting source statements; do not derive a rate.

Analysis details and source

Source reporting is internally inconsistent; no rate was reconstructed.

Recurrence by 6 months1 reported outcome
06
6 months, following 3-month success

Recurrence by 6 months

Recurrence defined as VAS >5 after success at 3 months participants; proportion not reported by group

The report states 30 total recurrences (23.3%) and no significant difference between groups (p=0.06). Group counts and denominators are not supplied in the narrative.

Analysis details and source

No group-specific effect can be estimated from the presented information.

Baropodometric plantar-pressure measures1 reported outcome
07
Baseline

Baropodometric plantar-pressure measures

Static baropodometry g/cm², cm² and percent as reported

Four participants lacked data; Table 2 lists n=65 ESWT and n=60 physiotherapy. Most measures did not differ between groups; left heel contact area did (54.2 (13.2) vs 48.5 (8.0) cm², p=0.005). Pain was correlated with plantar contact measures in the authors’ analysis. These baseline/association findings are not treatment effects.

Analysis details and source

Baseline comparison; multiple body-side measures and incomplete data.

Harms1 reported outcome
08
During treatment and follow-up

Harms

Adverse-event reporting events

The article does not describe a systematic adverse-event summary in its Results. This is unreported in the accessible article text, not evidence of zero events.

Analysis details and source

Harms were not adequately extractable; no event count inferred.

How treatment was delivered
Radial ESWT protocol

BTL-6000 radial device; 2,000 pulses at 10 Hz and 2.5 bar; six sessions once weekly.

Active comparator protocol

Twelve physiotherapy sessions over four weeks, three times weekly, combining plantar stretching, deep transverse massage and ultrasound.

Outcome assessment

VAS at baseline, immediately post-treatment and 1, 3, 6 and 12 months; blinded physician assessor. Roles and Maudsley score (RMS) at baseline, 3 and 12 months. Twelve-month follow-up was still ongoing in the report.

HARMS & TOLERABILITY

This report does not provide extractable systematic adverse-event counts. Do not interpret lack of a harms table as proof that no events occurred.

LIMITS OF THE ANALYSIS

VAS starts with a statistically significant baseline difference between groups, while follow-up comparisons are reported without a between-group effect estimate or confidence interval.

The success-rate narrative and Table 4 do not align cleanly; the article also presents more than one success definition.

The 12-month follow-up was still ongoing, despite a planned long-term assessment.

Findings checked against the full source by a separate automated reviewer.

Limitations noted by the reviewers

  • VAS starts with a statistically significant baseline difference between groups, while follow-up comparisons are reported without a between-group effect estimate or confidence interval.
  • The success-rate narrative and Table 4 do not align cleanly; the article also presents more than one success definition.
  • The 12-month follow-up was still ongoing, despite a planned long-term assessment.
Research review

Source-linked critical reading

Randomized comparative clinical trial

Reading depthMaterial consulted
Technical source record

Complete article XML read, including methods, results, tables, figure captions, discussion, conclusion and disclosures.

Review statusAI-assisted draft · independent automated checkThis automated check comes before the editor’s clinical review.
Design and evidence base

Two-arm randomized controlled study at one Tunisian hospital. The article reports 129 participants randomized (66 ESWT, 63 physiotherapy); four lacked baropodometric data. Follow-up at 12 months was still ongoing in the report.

Participants

Adults aged 18–70 with proximal plantar-fascia pain lasting over three months, tenderness and activity VAS ≥5. The report gives substantial baseline clinical characteristics, including an average symptom duration near 11 months.

Intervention

Radial BTL-6000: 2,000 pulses, 10 Hz, 2.5 bar, six weekly sessions. Comparator received 12 sessions over four weeks of plantar stretching, deep transverse massage and ultrasound three times weekly. These are different treatment packages.

Comparator

Active physiotherapy plus ultrasound, not sham. The study is open-label because treatments are recognizable, although pain assessment was by an assessor described as blinded.

Outcomes

VAS was assessed at baseline, end of treatment, 1, 3 and 6 months; 12-month follow-up was ongoing. Roles and Maudsley score was assessed at baseline and 3/12 months. Baropodometry was a secondary measure. The article’s success definitions are inconsistent.

Between-group interpretation

At 3 months, VAS means were 4.33 (SD 2.00) versus 4.5 (1.99), p=0.479; at 6 months 3.56 (2.48) versus 3.42 (2.21), p=0.751. No between-group effect estimate or interval is supplied. Baseline VAS differed (p=0.013). Success rates are reported as 54% vs 46% in prose, while table counts do not clearly support those percentages; no reconstruction is appropriate.

Harms

The Results do not supply a clear systematic harms summary. This reporting gap cannot be interpreted as no adverse events.

Limitations

Open-label treatment, baseline imbalances, unclear outcome denominators and conflicting success definitions limit inference. Follow-up was incomplete at 12 months. Baropodometric findings had four missing cases and are not treatment outcomes.

Applicability

The comparison concerns two multi-component care packages in adults with chronic plantar heel pain. It does not establish equivalence, prove one package superior, or isolate the effect of shock waves from the treatment context.

Research priorities

Future reports should prespecify one success definition, provide arm-specific denominators and adjusted between-group estimates with intervals, complete longer follow-up and systematically report adverse events.

THE ORIGINAL SOURCE

Read the original article.

The effectiveness of radial extracorporeal shock wave therapy (rESWT) in plantar fasciitis: a 12 months randomised controlled trial in a Tunisian rehabilitation department.

Ines L, Rihab M, Sana B, Saoussen L, Mariem G, Sinene F, Sonia J. · BMC musculoskeletal disorders · 2025

Open the publication record or available full-text files.

Checked against the full paper · Clinical review: Dr. Marcus Yu Bin Pai, · How we review →